The aMAP score improves discrimination of prognostic models in hepatocellular carcinoma after radiofrequency ablation
Luchang Fan, Yiyan Zhang, Jianmin Ding, Yan Zhou, Jun Li, Qiong Wu, Shuqin Cheng, Fengmei Wang, Xiang Jing · 2026
Read The aMAP score improves discrimination of prognostic models in hepatocellular carcinoma after radiofrequency ablation by Luchang Fan, Yiyan Zhang, Jianmin Ding, Yan Zhou, Jun Li, Qiong Wu, Shuqin Cheng, Fengmei Wang, Xiang Jing (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13318713.txt.
Description
Luchang Fan and colleagues present a 2026 retrospective study of liver cancer treated by radiofrequency ablation. They test whether the aMAP score predicts cancer returning after treatment. The score was built to forecast liver cancer risk in hepatitis patients. Its value after ablation was unclear.
The sample held 350 patients having ablation for the first time. A low score meant 63.55 or below, and 197 patients fell in that band. Low-score patients enjoyed longer recurrence-free survival. Adjusted analysis confirmed the score as an independent prognostic factor, with a hazard ratio of 1.40 reported. Adding the score to a tumour size and number model improved prediction. Reclassification gains reached 15.9 percent in their checks.
Catalog record
| CREATOR | Luchang Fan, Yiyan Zhang, Jianmin Ding, Yan Zhou, Jun Li, Qiong Wu, Shuqin Cheng, Fengmei Wang, Xiang Jing |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32086 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |